Skip to main content
OpenTrials
Completed

NCT Number: NCT02853695

Implementation of Hysteroscopy in Flanders and the Netherlands

By means of a questionnaire the investigators will study the implementation of hysteroscopy in Flanders and the Netherlands

Completed

Looking for future studies?

Notify Me

Key information

About this study

Hysteroscopy is a minimally invasive method for diagnosis and treatment of intra-uterine abnormalities. Complication and failure rates are low because of the direct visualisation of the treated abnormality. Moreover, hysteroscopic procedures replaced 'blind' (curettage) and more invasive interventions (hysterectomy).

The field of hysteroscopy has developed over the years. Changes occurred in hysteroscopic instruments and in the use of energy sources. An important development is the smaller diameter of the hysteroscopic system which makes it suitable for an outpatient setting. Not every gynaecologist, however, has the appropriate hysteroscopic skills or setting to carry out these procedures.

The incorporation of hysteroscopic procedures into daily practice in Flanders is unclear. In the Netherlands 2 surveys were conducted in the past to question the treatment options for polypectomy in an outpatient setting on the one hand and the diffusion of hysteroscopy on the other hand.

The investigators want to study the diffusion of hysteroscopy in Flanders and the Netherlands. Moreover the investigators want to provide an overview of the hysteroscopic procedures implemented, as well as the setting they are performed in.

An electronic questionnaire (LimeService) will be sent to all gynaecologists in Flanders and the Netherlands. Participation is voluntary and anonymous. After informed consent all gynaecologists are asked to complete the first part of the questionnaire containing general information. The second part is specific for gynaecologists performing hysteroscopy themselves, and inquires about the procedures they carry out.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • gynaecologist

Exclusion criteria

  • residents in training for gynaecology/obstetrics

Treatment and study plan

Primary outcomes

  1. Questionnaire: Implementation of hysteroscopy

    Time frame: August 2016, questionnaire will be sent once at the start of the study

    the amount of gynaecologists performing hysteroscopy in relation to the total of gynaecologists participating in the questionnaire

Secondary outcomes

  1. Questionnaire: setting for performing diagnostic hysteroscopy

    Time frame: August 2016, questionnaire will be sent once at the start of the study

    in which setting (office/operating room) diagnostic hysteroscopies are performed in relation to the total amount of diagnostic hysteroscopies performed

  2. Questionnaire:Instrumentation used for hysteroscopy

    Time frame: August 2016, questionnaire will be sent once at the start of the study

    which instrumentation is used for specific hysteroscopic procedures.

  3. Questionnaire: Diagnostic and techniques in the treatment of intrauterine pathology

    Time frame: August 2016, questionnaire will be sent once at the start of the study

    which diagnostics and techniques are used in the treatment of intrauterine pathology

Sponsors and collaborators

Lead sponsor

University Ghent

Other

Collaborators

  • Catharina Ziekenhuis Eindhoven
  • Dutch Society of Obstetricians and Gyneacologists (NVOG)
  • Vlaamse Vereniging voor Obstetrie en Gynaecologie

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Aug 3, 2016
Registry last updated
Jul 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.